Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 28, 2002
[The arginine paradox]Toshio Nakaki, Keiichi HishikawaArteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2004
Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient miceKeiichi Hishikawa, Toshio Nakaki, Toshiro FujitaThe Journal of Biological Chemistry|November 20, 2003
Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cellsMasahiko Watabe, Keiichi Hishikawa, Atsushi Takayanagi, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 11, 2002
Learning adverse drug effects from judicial precedentsToshio NakakiEuropean Journal of Pharmacology|October 7, 2004
Reduced renal ClC-5 Cl- channel expression in spontaneously hypertensive rats with microalbuminuriaKaro Tanaka, Toshio NakakiInternational Journal of Molecular Sciences|October 23, 2013
Impaired glutathione synthesis in neurodegenerationKoji Aoyama, Toshio NakakiAmino Acids|March 7, 2013
Neuroprotective properties of the excitatory amino acid carrier 1 (EAAC1)Koji Aoyama, Toshio NakakiMolecular Pharmacology|July 5, 2008
Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cellsMasahiko Watabe, Toshio NakakiNeuropharmacology|October 10, 2006
ATP depletion does not account for apoptosis induced by inhibition of mitochondrial electron transport chain in human dopaminergic cellsMasahiko Watabe, Toshio NakakiThe Journal of Pharmacology and Experimental Therapeutics|July 29, 2004
Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cellsMasahiko Watabe, Toshio NakakiPageof 8